Author | Neufeld, Paulo Murillo | |
Author | Melhem, Marcia de Souza Carvalho | |
Author | Szeszs, Maria Walderez | |
Author | Ribeiro, Marcos Dornelas | |
Author | Amorim, Efigenia de Lourdes Teixeira | |
Author | Silva, Manuela da | |
Author | Lazera, Marcia Dos Santos | |
Access date | 2015-09-28T18:59:21Z | |
Available date | 2015-09-28T18:59:21Z | |
Document date | 2015 | |
Citation | NEUFELD, Paulo Murillo et al. Nosocomial candidiasis in Rio de Janeiro State: Distribution and fluconazole susceptibility profile. Braz. J. Microbiol., São Paulo, v. 46, n. 2, p. 477-484, 2015. | pt_BR |
ISSN | 1678-4405 | |
URI | https://www.arca.fiocruz.br/handle/icict/11838 | |
Language | eng | pt_BR |
Publisher | Sociedade Brasileira de Microbiologia | pt_BR |
Rights | open access | pt_BR |
Subject in Portuguese | Candida | pt_BR |
Subject in Portuguese | Fluconazol | pt_BR |
Subject in Portuguese | Antifúngicos | pt_BR |
Title | Nosocomial candidiasis in Rio de Janeiro State: Distribution and fluconazole susceptibility profile | pt_BR |
Type | Article | pt_BR |
DOI | 10.1590/S1517-838246220120023 | |
Abstract | One hundred and forty-one Candida species isolated from clinical specimens of hospitalized patients in Rio de Janeiro, Brazil, during 2002 to 2007, were analized in order to evaluate the distribution and susceptibility of these species to fluconazole. Candida albicans was the most frequent species (45.4%), followed byC. parapsilosis sensu lato (28.4%), C. tropicalis (14.2%), C. guilliermondii (6.4%),C. famata (2.8%), C. glabrata (1.4%), C. krusei (0.7%) and C. lambica (0.7%). The sources of fungal isolates were blood (47.5%), respiratory tract (17.7%), urinary tract (16.3%), skin and mu-cous membrane (7.1%), catheter (5.6%), feces (2.1%) and mitral valve tissue (0.7%). The susceptibility test was performed using the methodology of disk-diffusion in agar as recommended in theM44-A2 Document of the Clinical and Laboratory Standards Institute (CLSI). The majority of the clinical isolates (97.2%) was susceptible (S) to fluconazole, although three isolates (2.1%) were susceptible-dose dependent (S-DD) and one of them (0.7%) was resistant (R). The S-DD isolates were C. albicans, C. parapsilosis sensu lato and C. tropicalis. One isolate of C. krusei was resistant to fluconazole. This work documents the high susceptibility to fluconazole by Candida species isolated in Rio de Janeiro, Brazil. | pt_BR |
Affilliation | Universidade Federal do Rio de Janeiro. Departamento de Análises Clínicas e Toxicológicas. Rio de Janeiro, RJ, Brasil / Fundação Oswaldo Cruz. Instituto Nacional de Controle de Qualidade em Saúde. Rio de Janeiro, RJ, Brasil. | pt_BR |
Affilliation | Instituto Adolfo Lutz. Serviço de Parasitologia. São Paulo, SP, Brasil. | pt_BR |
Affilliation | Instituto Adolfo Lutz. Serviço de Parasitologia. São Paulo, SP, Brasil. | pt_BR |
Affilliation | Instituto Estadual de Hematologia Arthur da Siqueira Cavalcante. Serviço de Patologia Clínica. Rio de Janeiro, RJ, Brasil. | pt_BR |
Affilliation | Laboratório Sérgio Franco. Setor de Microbiologia e Urinálise. Rio de Janeiro, RJ, Brasil. | pt_BR |
Affilliation | Fundação Oswaldo Cruz. Instituto Nacional de Controle de Qualidade em Saúde. Rio de Janeiro, RJ, Brasil. | pt_BR |
Affilliation | Fundação Oswaldo Cruz. Instituto de Pesquisa Clínica Hospital Evandro Chagas. Laboratório de Micologia. Rio de Janeiro, RJ, Brasil. | pt_BR |
Subject | Candida | pt_BR |
Subject | Fluconazole | pt_BR |
Subject | Antifungal Susceptibility | pt_BR |
Subject | Disk Diffusion | pt_BR |
DeCS | Candida | pt_BR |
DeCS | Fluconazol | pt_BR |
DeCS | Antifúngicos | pt_BR |
DeCS | Testes de Sensibilidade a Antimicrobianos por Disco-Difusão | pt_BR |